Silicon Laboratories Inc. key statistics and ratios

In fiscal 2025, Silicon Laboratories Inc. had return on equity of -6.0%, an operating margin of -9.0%, debt equal to 0.0% of equity and a current ratio of 4.69. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Silicon Laboratories Inc.: financial ratios, annual
Fiscal year	2009Jan 2010	2010Jan 2011	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Jan 2015	2015Jan 2016	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Jan 2021	2021Jan 2022	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Jan 2026	LTMJul 2026
Gross margin	63.4%	65.7%	60.7%	60.0%	60.8%	61.0%	59.0%	60.4%	59.1%	60.1%	59.1%	57.7%	59.0%	62.7%	58.9%	53.4%	58.2%	60.6%
Operating margin	15.1%	17.6%	10.2%	15.2%	11.1%	8.3%	5.0%	9.5%	11.1%	9.8%	−18.7%	−21.0%	−4.6%	11.6%	−3.1%	−28.3%	−9.0%	−5.1%
Net margin	16.6%	14.8%	7.2%	11.3%	8.6%	6.1%	4.6%	8.8%	6.1%	9.6%	4.1%	2.5%	293.7%	8.9%	−4.4%	−32.7%	−8.3%	−4.6%
Free-cash-flow margin	25.4%	21.1%	16.3%	−0.9%	18.9%	20.3%	14.6%	16.9%	23.1%	17.2%	31.9%	23.0%	8.7%	11.2%	−6.7%	−4.4%	8.4%	−0.6%
Return on equity	11.6%	11.7%	5.8%	10.2%	7.2%	5.1%	3.9%	7.7%	5.3%	8.3%	1.8%	1.1%	124.1%	5.1%	−2.6%	−16.7%	−6.0%	−3.6%
Return on assets	9.8%	10.0%	4.9%	8.1%	5.3%	3.7%	2.9%	5.9%	3.6%	5.3%	1.2%	0.7%	85.5%	3.6%	−1.9%	−14.3%	−5.2%	−3.1%
Asset turnover	0.59	0.67	0.69	0.71	0.62	0.61	0.63	0.67	0.59	0.55	0.29	0.28	0.29	0.40	0.43	0.44	0.63	0.68
Current ratio	5.91	6.19	5.47	4.40	4.21	3.24	2.97	3.51	5.84	5.71	6.85	3.43	3.35	7.87	4.51	6.15	4.69	5.41
Debt to equity	0.0%	0.0%	0.0%	15.4%	12.9%	11.5%	10.2%	8.8%	35.9%	33.2%	33.0%	47.0%	—	37.7%	—	0.0%	0.0%	0.0%
Interest cover (operating income ÷ interest)	—	—	—	74.6x	19.5x	16.3x	11.4x	25.6x	—	4.3x	n/m	n/m	n/m	17.7x	n/m	n/m	n/m	n/m
Effective tax rate	−6.0%	16.4%	32.2%	26.4%	19.7%	22.5%	2.2%	4.7%	38.8%	−15.8%	—	—	—	29.6%	—	—	—	—
R&D as % of revenue	23.7%	25.1%	27.7%	24.5%	27.2%	27.9%	29.2%	28.6%	27.2%	27.5%	43.4%	46.0%	37.9%	32.5%	43.2%	56.9%	45.0%	42.2%
SG&A as % of revenue	24.7%	23.1%	22.9%	20.3%	22.5%	24.8%	24.9%	22.3%	20.8%	22.8%	34.4%	32.6%	25.7%	18.6%	18.8%	24.9%	22.2%	23.5%
Capital spending as % of revenue	2.0%	2.8%	1.8%	18.1%	1.8%	1.8%	1.7%	1.6%	1.6%	2.8%	3.2%	3.5%	4.0%	2.6%	2.8%	2.0%	3.8%	4.5%
Free cash flow ÷ net income	153.2%	142.1%	225.7%	−7.9%	220.2%	332.0%	318.3%	191.9%	376.4%	178.3%	785.0%	938.7%	3.0%	125.5%	—	—	—	—
Dividends and buybacks ÷ free cash flow	18.0%	134.8%	137.5%	—	23.7%	56.8%	75.9%	34.4%	—	26.3%	17.7%	13.8%	>999%	769.9%	—	—	0.0%	—

US$ thousands unless shown otherwise. Fiscal quarters.

Silicon Laboratories Inc.: financial ratios, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Apr 2025	2025 Q2Jul 2025	2025 Q3Oct 2025	2025 Q4Jan 2026	2026 Q1Apr 2026	2026 Q2Jul 2026
Gross margin	54.3%	54.3%	55.0%	56.1%	57.8%	63.4%	59.5%	61.6%
Operating margin	−17.9%	−17.2%	−18.1%	−11.9%	−6.0%	−1.6%	−8.0%	−4.7%
Net margin	−17.1%	−14.3%	−17.1%	−11.3%	−4.8%	−1.3%	−7.4%	−4.6%
Free-cash-flow margin	17.7%	3.7%	24.4%	−2.0%	13.6%	−0.8%	−2.3%	−11.8%
Current ratio	5.19	6.15	5.17	5.12	4.49	4.69	5.11	5.41
R&D as % of revenue	50.0%	49.6%	49.6%	45.5%	42.6%	43.0%	41.5%	41.6%
SG&A as % of revenue	22.1%	21.9%	23.4%	22.4%	21.2%	22.0%	26.0%	24.7%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

2 of 3 checks passed · July 4, 2026

What it owns · $1.3bn

Short-term assets $671mLonger-term assets $582m

What it owes, and who funded it · $1.3bn

Short-term liabilities $124mLonger-term liabilities $34mShareholders' equity $1.1bn

Short-term assets cover short-term liabilities $671m of assets due within a year against $124m of liabilities due within a year.
Short-term assets cover long-term liabilities $671m short-term assets against $34m of longer-dated liabilities.
More cash than debt Cash or debt not separately reported. Not assessable.
Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
Operating profit covers interest at least five times over Operating income of −$43m against $923,000 of interest.

From Silicon Laboratories Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

67 /100

Moderate moat

How hard Silicon Laboratories's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

Returns on capital 20 / 20

Cash operating profit has been a median 18.0% of total assets over 10 years.
Pricing power 19 / 20

Gross margin has been a median 59.8%, moving by 2.6 percentage points (standard deviation) across 10 years.
Durability 0 / 20

Operating margin has been a median 0.7%; its worst year was -33.3%.
Cash conversion 15 / 20

Free cash flow was positive in 8 of 10 years, at a median 13.1% of revenue.
Discipline 13 / 20

The diluted share count fell 27.1% over five years; stock-based pay has been a median 7.4% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: PLAB vs SLAB HIMX vs SLAB SIMO vs SLAB FORM vs SLAB

More: Semiconductors stocks compared, Technology sector, rankings of US companies

Figures from Silicon Laboratories Inc.'s SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Silicon Laboratories Inc.